ByteDance’s Anew Labs Raises $290 Million in First External Round

Summarized by NextFin AI

Anew Labs, the AI drug discovery company spun out of ByteDance, has completed a $290 million fundraising round, marking its first independent financing according to people familiar with the matter.
The round was led by HSG (formerly Sequoia China), IDG Capital and Hillhouse Investment, with 5Y Capital as a co-lead, plus Gaorong Ventures and several strategic pharmaceutical investors.
The financing values the Shanghai-based company at about $1.5 billion, with ByteDance retaining a majority stake in the new entity.
Anew Labs was formed after ByteDance separated its AI pharmaceutical business line earlier this year, transferring core team, algorithms and pipeline assets into the new company.

NextFin News — Anew Labs, the AI drug discovery company spun out of ByteDance, has completed a $290 million fundraising round, its first independent financing, according to people familiar with the matter.

The round was led by HSG (formerly Sequoia China), IDG Capital and Hillhouse Investment, with 5Y Capital as a co-lead. Other participants included Gaorong Ventures and several strategic investors from the pharmaceutical sector. The financing values the Shanghai-based company at about $1.5 billion, with ByteDance retaining a majority stake.

Anew Labs was formed after ByteDance separated its AI pharmaceutical business line earlier this year, transferring the core team, algorithms and pipeline assets into the new entity.

Explore more exclusive insights at nextfin.ai.

Insights

What is Anew Labs AI drug model?

How did ByteDance spin out Anew?

What is AI drug discovery tech?

Where is Anew Labs company based?

What assets did ByteDance transfer?

Who led the Anew Labs funding round?

What is Anew Labs current valuation?

Does ByteDance keep majority stake?

Who are Anew Labs new investors?

Why did ByteDance spin out unit?

How much money was raised total?

Is this first external funding round?

When was Anew Labs company formed?

What core team assets moved over?

How will funds be used now?

What is Anew Labs future growth plan?

Can AI drug discovery succeed?

What main risks face Anew Labs?

Who are Anew Labs key competitors?

How does Anew Labs compare rivals?

NextFin.Al

No Noise, only Signal.

Open App